| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Crizotinib | gCSI | pan-cancer | AAC | 0.012 | 0.8 |
| mRNA | ML311 | CTRPv2 | pan-cancer | AAC | 0.0069 | 0.8 |
| mRNA | CAY10594 | CTRPv2 | pan-cancer | AAC | 0.0079 | 0.8 |
| mRNA | Cyclopamine | FIMM | pan-cancer | AAC | 0.033 | 0.8 |
| mRNA | PI-103 | CTRPv2 | pan-cancer | AAC | 0.0072 | 0.8 |
| mRNA | BI-2536 | CTRPv2 | pan-cancer | AAC | 0.0064 | 0.8 |
| mRNA | Axitinib | FIMM | pan-cancer | AAC | -0.034 | 0.8 |
| mRNA | AT-7519 | GDSC1000 | pan-cancer | AAC | -0.0061 | 0.8 |
| mRNA | CEP-701 | FIMM | pan-cancer | AAC | -0.026 | 0.8 |
| mRNA | BRD-M00053801 | CTRPv2 | pan-cancer | AAC | 0.0095 | 0.8 |